Page last updated: 2024-08-26

vinpocetine and Cognition Disorders

vinpocetine has been researched along with Cognition Disorders in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's1 (9.09)18.2507
2000's6 (54.55)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aliev, KT; Lalayan, TV; Pugachova, EL; Skoromets, AA; Smolko, DG1
Konchugova, TV; Orekhova, EM; Prikazchikova, OA; Raĭgorodskiĭ, IuM; Svistunov, AA1
Bedi, KL; Deshmukh, R; Mehan, S; Sharma, N; Sharma, V1
Lobzin, VIu; Odinak, MM1
Antipenko, EA; Davydova, TA; Emelin, AIu; Fedorova, IaB; Gavrilova, SI; Gustov, AV; Kalyn, IaB; Kashin, AV; Kolykhalov, IV; Korshunova, IuA; Messler, G; Odinak, MM; Roshchina, IF; Selezneva, ND1
Balogh, A; Fehér, G; Késmárky, G; Misnyovszky, M; Nagy, K; Németh, G; Németh, GY; Szapáry, L; Tóth, K; Tóth, T1
Szatmari, SZ; Whitehouse, PJ1
Valikovics, A1
Kidd, PM1
Horváth, S1
Astengo, F; Balestreri, R; Fontana, L1

Reviews

4 review(s) available for vinpocetine and Cognition Disorders

ArticleYear
[Vinpocetin in neurological diseases].
    Ideggyogyaszati szemle, 2012, Nov-30, Volume: 65, Issue:11-12

    Topics: Animals; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia, Vascular; Hemorheology; Humans; Microcirculation; Nervous System Diseases; Neuroprotective Agents; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids

2012
Vinpocetine for cognitive impairment and dementia.
    The Cochrane database of systematic reviews, 2003, Issue:1

    Topics: Alzheimer Disease; Cognition Disorders; Dementia; Dementia, Vascular; Humans; Nootropic Agents; Randomized Controlled Trials as Topic; Vinca Alkaloids

2003
A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
    Alternative medicine review : a journal of clinical therapeutic, 1999, Volume: 4, Issue:3

    Topics: Acetylcarnitine; Cognition Disorders; Complementary Therapies; Dementia; Ginkgo biloba; Humans; Nootropic Agents; Phosphatidylserines; Phytotherapy; Plant Extracts; Plants, Medicinal; Risk Factors; Vinca Alkaloids

1999
[The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
    Orvosi hetilap, 2001, Feb-25, Volume: 142, Issue:8

    Topics: Calcium Channel Blockers; Cerebrovascular Circulation; Chronic Disease; Clinical Trials as Topic; Cognition; Cognition Disorders; Germany; Humans; Hypoxia, Brain; Italy; Japan; Memory; Memory Disorders; Neuroprotective Agents; Nootropic Agents; Severity of Illness Index; Sodium Channels; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids

2001

Trials

5 trial(s) available for vinpocetine and Cognition Disorders

ArticleYear
[Cognitive functions and treatment of their impairment in elderly patients with the vertebrobasilar issufficiensy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2013, Volume: 113, Issue:4

    Topics: Aged; Cognition Disorders; Female; Humans; Male; Middle Aged; Neurologic Examination; Neuroprotective Agents; Treatment Outcome; Vasodilator Agents; Vertebrobasilar Insufficiency; Vinca Alkaloids

2013
[Efficacy of dynamic magnetic therapy in the complex treatment of cognitive disturbances in patients with chronic cerebrovascular insufficiency].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:2

    Topics: Aged; Antihypertensive Agents; Brain; Cerebrovascular Disorders; Cognition Disorders; Female; Humans; Magnetic Field Therapy; Male; Middle Aged; Treatment Outcome; Vinca Alkaloids

2009
[Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive imp
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Amino Acids; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Syndrome; Time Factors; Treatment Outcome; Vinca Alkaloids

2010
[Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Ideggyogyaszati szemle, 2007, Jul-30, Volume: 60, Issue:7-8

    Topics: Administration, Oral; Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dementia, Vascular; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Nootropic Agents; Pilot Projects; Psychometrics; Severity of Illness Index; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids

2007
A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.
    Journal of the American Geriatrics Society, 1987, Volume: 35, Issue:5

    Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Placebos; Time Factors; Vasodilator Agents; Vinca Alkaloids

1987

Other Studies

2 other study(ies) available for vinpocetine and Cognition Disorders

ArticleYear
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.
    European journal of pharmacology, 2009, Oct-12, Volume: 620, Issue:1-3

    Topics: Acetylcholinesterase; Animals; Behavior, Animal; Cerebral Ventricles; Cognition Disorders; Glutathione; L-Lactate Dehydrogenase; Male; Malondialdehyde; Maze Learning; Memory; Motor Activity; Nitrites; Oxidative Stress; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Streptozocin; Vinca Alkaloids

2009
[The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Nootropic Agents; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids

2009